Exhausted by chronic, undiagnosed itch?

This Phase 2 study could be for you

The Chronic Itch Study is evaluating the effects of an investigational medication in adults with chronic pruritus of unknown origin (CPUO). Researchers also want to learn how the investigational medication works in the body and the effect it has on CPUO. You may be eligible if you:

  • Are 18 years of age or older
  • Have experienced pruritus affecting at least 4 body areas for the past 6 months or more
See If You Qualify
Multi Square Graphic
graphic-icons

If you’re able to participate, you’ll receive the following at no cost:

  • The study medication
  • Study-related tests and procedures
  • Reimbursement for study-related costs

What does study participation involve?

Enrolling in the study: You’ll be given all the details about participation, including potential benefits and risks. Then, the study team will perform tests to determine if this study is a good fit for you.

Study duration: You will be in the study for up to 28 weeks through a 2 to 4-week screening period, a 16-week intervention (treatment) period, and an 8-week follow-up period.

Study tests and procedures: There are many tests in this study, including blood tests, ECGs, and complete physical examinations. The study team can explain these tests and their frequency in more detail.

Study medication: The investigational medication will be compared to a placebo, which does not have any active medication in it. You will be randomly assigned to receive either the investigational medicine or a placebo by subcutaneous (SC) injection.

What is a clinical study?

Clinical studies are designed to test investigational or approved drugs to see if they’re safe and they work. Approved drugs may be tested to collect additional data or to evaluate them in new settings, such as in treating a new condition. They’re conducted by experienced medical professionals who monitor your health throughout the clinical study. They’re also reviewed by Regulatory Health Agencies, the Institutional Review Board (IRB), and ethics committees (ECs) to make sure they’re safe.

Clinical studies are the only way to develop new treatments and improve patient care. This clinical study will help researchers learn more about the safety, tolerability, and effectiveness of the investigational medication.

See If You Qualify
graphic-icons

Frequently asked questions (FAQs)

Consider participating

If you’re an adult who has been diagnosed with CPUO and experience chronic, relentless itch, this clinical study may be an option for you.

If you qualify and are able to participate, you will receive the following at no cost:

  • The study medication
  • Study-related tests and procedures
  • Reimbursement for costs related to attending study visits
See If You Qualify